socalTECH
JULY 17, 2014
According to the report, there was $472.15M invested in Los Angeles, $222.4M invested in San Diego, and $66.53M invested in Orange County during the period. for San Diego-based biopharmaceuticals firm Otonomy ; and $48.0M for San Diego''s Veredezyne , which is developing biofuels and biochemicals processes.
socalTECH
SEPTEMBER 27, 2018
LAVA also said it has added Chris Wadden, the President of the Pasadena Angels as Treasurer of the group, and Shuki Lehavi, the CEO of Amiggi, as its secretary. LAVA's day to day operations are managed by Executive Director Len Lanzai.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
socalTECH
NOVEMBER 18, 2014
San Diego-based Alyllix , which produces flavors, fragrances, and other ingredients using yeast fermentation, has been acquired by Swiss company Evolva Holdings SA. allylix evolva flavors fragrances merger acquisition tech coast angels' Evolva said it will acquire Allylix in return for 46 million shares of the company.
socalTECH
JANUARY 17, 2013
Los Angeles had a total of $311.25M in deals for the quarter, followed by Orange County with $197.8M, then San Diego, with $174.6M In terms of industries, biotechonlogy actually led the region, with a total of $134.87M in funding; the majority of those funding deals were in the San Diego area. in funding.
socalTECH
JULY 18, 2013
San Diego-based Yapert said this morning that it has raised $1.2M According to the firm, the funding was led by the Tech Coast Angels, and also included the Desert Angels, Pasadena Angels, and other independent angel investors. in a seed funding round, for its interactive mobile magazine.
socalTECH
OCTOBER 18, 2012
In Los Angeles, near $324.2M was invested across 48 deals; San Diego has $241.5M In terms of venture capital, the most active investors in Southern California companies were the Pasadena Angels with 8 deals, Siemer Ventures (7 deals); Versant Ventures (5 deals); and GRP Partners (5 deals). in investments.
socalTECH
APRIL 14, 2010
San Diego-based Allylix , which is developing chemical products for the flavor and fragrance industry, said yesterday that it has closed out its Series C funding round at $9M. The firm had closed an initial $6M in its Series C round February. Allylix is developing terpenes, which are used by the food and fragrance industry.
Expert insights. Personalized for you.
240 
Let's personalize your content